How Trends in Corporate Consolidation Reflect in Biden’s Healthcare Anti-Trust Action

Earlier this month, President Joe Biden signed an executive order that addresses competition among hospitals, health insurers, prescription drugmakers, and hearing aid manufacturers in an effort to tackle anti-competitive practices in various industries.

The order urges the Department of Justice and the Federal Trade Commission to crack down on antitrust laws and actively revise merger guidelines to ensure patient safety. However, how will these actions impact mergers and acquisitions in general?

To further investigate this question, as well as to evaluate the incentives behind corporate consolidation in today’s economy, Daniel Litwin, the Voice of B2B, invited Dr. Susan Clark Muntean, associate professor of management and accountancy at UNC Asheville, to this episode of MarketScale TV.

The two consider what impact the trends toward M&As have had on patient access to healthcare, as well as who typically benefits from corporate mergers and acquisitions in the long term.

“That question should always be asked to look at projected outcomes and the impact of mergers and acquisitions. Who benefits, who doesn’t, and who is harmed or potentially could be harmed,” explains Dr. Clark Muntean.

They also discuss some of the responses from industry organizations to the executive order, how the primary motivators for corporate consolidation have evolved over the years and the overall effectiveness of anti-trust regulations in combatting anti-competitive practices.

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale

Follow us on social media for the latest updates in B2B!

Image

Latest

Mission
Why Is the Mission of Benchmark So Important
December 23, 2025

As pharmaceutical innovation accelerates, the margin for error narrows, making quality assurance not just a regulatory necessity but a public good. Benchmark’s mission sits at the intersection of progress and protection—helping manufacturers stay aligned with FDA standards so life-saving therapies reach patients faster and safer. By keeping cleanrooms compliant and companies out of trouble, Benchmark…

Read More
Benchmark
What Is It Like for You to Be Part of the Benchmark Products Teams Now
December 23, 2025

Being part of the Benchmark Products team today means working at the intersection of precision manufacturing and deeply human collaboration, especially in the high-stakes world of cleanroom and sterility assurance solutions. As the organization grows, employees describe a culture that still feels familial—one where clear communication, personal accountability, and genuine care for customers drive…

Read More
Cleaning
Do Your Friends Ever Ask You For Cleaning Tips
December 23, 2025

In a media landscape increasingly shaped by privacy constraints, data clean rooms have emerged as a quiet but powerful way for brands to collaborate without exposing sensitive information, even if, as Will Sepsis quips, some partners would still prefer that “ignorance is bliss.” That tension—between curiosity and caution—captures the moment we’re in, where understanding…

Read More
Clean
Do You Friends Ask You For Cleaning Methods or Clean Their Home
December 23, 2025

At Benchmark Products, where cleanroom precision is part of everyday work, professionals often discover that specialized knowledge doesn’t always translate neatly into casual conversations—especially when friends jokingly wonder if you’ll critique their homes or turn them into germaphobes. The reality is that cleanroom science is about controlled environments and risk mitigation at an industrial scale,…

Read More